View in EDS

Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency.

Saved in:
Bibliographic Details
Title: Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency.
Authors: Parta M; Clinical Research Directorate, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: mark.parta@nih.gov., Cole K; Nursing Department, Clinical Center, National Institutes of Health, Bethesda, Maryland., Avila D; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Duncan L; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Baird K; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Schuver BB; Office of the Clinical Director, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wilder J; Clinical Research Directorate, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Palmer C; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Daub J; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Hsu AP; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Zerbe CS; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Marciano BE; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Cuellar-Rodriguez JM; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Bauer TR; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Nason M; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Calvo KR; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland., Merideth M; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland., Stratton P; Office of the Clinical Director, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, Maryland., DeCherney A; National Institute of Child Health and Development, National Institutes of Health, Bethesda, Maryland., Shah NN; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Holland SM; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Hickstein DD; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2021 May; Vol. 27 (5), pp. 435.e1-435.e11. Date of Electronic Publication: 2021 Jan 03.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33965189
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Parta+M%22">Parta M</searchLink>; Clinical Research Directorate, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland. Electronic address: mark.parta@nih.gov.<br /><searchLink fieldCode="AU" term="%22Cole+K%22">Cole K</searchLink>; Nursing Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Avila+D%22">Avila D</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Duncan+L%22">Duncan L</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Baird+K%22">Baird K</searchLink>; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Schuver+BB%22">Schuver BB</searchLink>; Office of the Clinical Director, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Wilder+J%22">Wilder J</searchLink>; Clinical Research Directorate, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland.<br /><searchLink fieldCode="AU" term="%22Palmer+C%22">Palmer C</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Daub+J%22">Daub J</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Hsu+AP%22">Hsu AP</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Zerbe+CS%22">Zerbe CS</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Marciano+BE%22">Marciano BE</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Cuellar-Rodriguez+JM%22">Cuellar-Rodriguez JM</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Bauer+TR%22">Bauer TR</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Nason+M%22">Nason M</searchLink>; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Calvo+KR%22">Calvo KR</searchLink>; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Merideth+M%22">Merideth M</searchLink>; National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Stratton+P%22">Stratton P</searchLink>; Office of the Clinical Director, National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22DeCherney+A%22">DeCherney A</searchLink>; National Institute of Child Health and Development, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Shah+NN%22">Shah NN</searchLink>; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Holland+SM%22">Holland SM</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Hickstein+DD%22">Hickstein DD</searchLink>; Immune Deficiency-Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101774629%22">Transplantation and cellular therapy</searchLink> [Transplant Cell Ther] 2021 May; Vol. 27 (5), pp. 435.e1-435.e11. <i>Date of Electronic Publication: </i>2021 Jan 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101774629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666367%22">26666367 </searchLink><i>NLM ISO Abbreviation: </i>Transplant Cell Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33965189
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jtct.2020.12.028
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 435.e1-435.e11
    Titles:
      – TitleFull: Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parta M
      – PersonEntity:
          Name:
            NameFull: Cole K
      – PersonEntity:
          Name:
            NameFull: Avila D
      – PersonEntity:
          Name:
            NameFull: Duncan L
      – PersonEntity:
          Name:
            NameFull: Baird K
      – PersonEntity:
          Name:
            NameFull: Schuver BB
      – PersonEntity:
          Name:
            NameFull: Wilder J
      – PersonEntity:
          Name:
            NameFull: Palmer C
      – PersonEntity:
          Name:
            NameFull: Daub J
      – PersonEntity:
          Name:
            NameFull: Hsu AP
      – PersonEntity:
          Name:
            NameFull: Zerbe CS
      – PersonEntity:
          Name:
            NameFull: Marciano BE
      – PersonEntity:
          Name:
            NameFull: Cuellar-Rodriguez JM
      – PersonEntity:
          Name:
            NameFull: Bauer TR
      – PersonEntity:
          Name:
            NameFull: Nason M
      – PersonEntity:
          Name:
            NameFull: Calvo KR
      – PersonEntity:
          Name:
            NameFull: Merideth M
      – PersonEntity:
          Name:
            NameFull: Stratton P
      – PersonEntity:
          Name:
            NameFull: DeCherney A
      – PersonEntity:
          Name:
            NameFull: Shah NN
      – PersonEntity:
          Name:
            NameFull: Holland SM
      – PersonEntity:
          Name:
            NameFull: Hickstein DD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2021 May
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2666-6367
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Transplantation and cellular therapy
              Type: main
ResultId 1